Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Michael S. Epstein; Eric D. Shah; Parakkal Deepak; Vladimir M. Kushnir

doi:10.14309/ajg.0000000000000215

Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Michael S. Epstein, Eric D. Shah, Parakkal Deepak, Vladimir M. Kushnir

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1017-1019
Number of pages	3
Journal	American Journal of Gastroenterology
Volume	114
Issue number	7
DOIs	https://doi.org/10.14309/ajg.0000000000000215
State	Published - Jul 2019

Access to Document

10.14309/ajg.0000000000000215

Cite this

@article{e384e546561e4c14b70cc3ca80560991,

title = "Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program",

author = "Epstein, {Michael S.} and Shah, {Eric D.} and Parakkal Deepak and Kushnir, {Vladimir M.}",

year = "2019",

month = jul,

doi = "10.14309/ajg.0000000000000215",

language = "English",

volume = "114",

pages = "1017--1019",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

number = "7",

}

TY - JOUR

T1 - Beyond the Label

T2 - Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

AU - Epstein, Michael S.

AU - Shah, Eric D.

AU - Deepak, Parakkal

AU - Kushnir, Vladimir M.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85069273889&partnerID=8YFLogxK

U2 - 10.14309/ajg.0000000000000215

DO - 10.14309/ajg.0000000000000215

M3 - Comment/debate

C2 - 31033521

AN - SCOPUS:85069273889

SN - 0002-9270

VL - 114

SP - 1017

EP - 1019

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 7

ER -

Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program

Access to Document

Other files and links

Cite this